UBS Group »

Adicet Bio Ord shares owned by UBS Group

Quarter-by-quarter ownership of Adicet Bio Ord (ACET) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Adicet Bio Ord

Tip: Access up to 7 years of quarterly data

All positions including Adicet Bio Ord held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adicet Bio Ord by UBS Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $32k 3.8k 8.42

More positions owned by UBS Group

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Ubs Group SHS (UBS)
Ishares Tr Russell 2000 Etf (IWM)
Spdr Gold Tr Gold Shs (GLD)
Tesla Motors (TSLA)

View all positions for UBS Group

Top funds holding Adicet Bio Ord

Franklin Resources
Vanguard Group
Renaissance Technologies
Goldman Sachs Group
Stonepine Capital Management
Alyeska Investment Group
Acadian Asset Management
ADAR1 Capital Management
Geode Capital Management
Luminus Management
State Street Corporation
Barclays
GSA Capital Partners
FNY Investment Advisers
UBS Group

View all funds holding Adicet Bio Ord